Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-02

Clinical Trial Update: Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Completion of a post-marketing drug use investigation for Zyvox (linezolid) to fulfill regulatory commitments, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYVOX (LINEZOLID)

Snippet

Sponsor: Pfizer | Conditions: Staphylococcal Infections | Status: COMPLETED | Results posted: 2012-07-02